Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 95

Sort by

Sort Order Select

Journal Articles

Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis

Magnus F.G. Grøndahl, Andreas H. Lange, Malte P. Suppli, Jonatan I. Bagger, Mira Thing, Lise L. Gluud, Dea H. Kofod, Mads Hornum, Gerrit van Hall, Samuel A.J. Trammell, Trisha J. Grevengoed, Bolette Hartmann, Jens J. Holst, Tina Vilsbøll, Mikkel B. Christensen, Asger B. Lund, Filip K. Knop

Diabetes 2024;73(10):1641–1647

https://doi.org/10.2337/db24-0305

Published: 25 July 2024

View article titled, Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis

Meeting Abstracts

909-P: Impact of SGLT2 Inhibition on Glucosuria in HNF1A-MODY

HENRIK MAAGENSEN, JOHANNE S. JENSEN, STINE OFFERSGAARD HØYERUP, ANNE CATHRINE B. THUESEN, JESPER KROGH, PETER ROSSING, TORBEN HANSEN, FILIP K. KNOP, SOFIE HAEDERSDAL, TINA VILSBØLL

Diabetes 2024;73(Supplement_1):909-P

https://doi.org/10.2337/db24-909-P

Published: 14 June 2024

View article titled, 909-P: Impact of SGLT2 Inhibition on Glucosuria in HNF1A-MODY

Meeting Abstracts

1598-P: Transcriptional Profiling of the Intestinal Tract in Type 2 Diabetes—Unraveling Pathophysiological Pathways for Therapeutic Insights

HANNAH GILLIAM-VIGH, ANNE-MARIE ELLEGAARD, MARTIN R. MADSEN, BENJAMIN A.H. JENSEN, KRISTOFFER RIGBOLT, FILIP K. KNOP

Diabetes 2024;73(Supplement_1):1598-P

https://doi.org/10.2337/db24-1598-P

Published: 14 June 2024

View article titled, 1598-P: Transcriptional Profiling of the Intestinal Tract in Type 2 Diabetes—Unraveling Pathophysiological Pathways for Therapeutic Insights

Meeting Abstracts

53-OR: Efficacy and Safety of Coadministered s.c. Semaglutide and s.c. Cagrilintide in Type 2 Diabetes

JUAN P. FRIAS, SRIKANTH DEENADAYALAN, LARS ERICHSEN, FILIP K. KNOP, ILDIKO LINGVAY, STANISLAVA MACURA, CHANTAL MATHIEU, SUE D. PEDERSEN, MELANIE J. DAVIES

Diabetes 2023;72(Supplement_1):53-OR

https://doi.org/10.2337/db23-53-OR

Published: 23 June 2023

View article titled, 53-OR: Efficacy and Safety of Coadministered s.c. Semaglutide and s.c. Cagrilintide in Type 2 Diabetes

Meeting Abstracts

54-OR: Effect of Coadministered s.c. Semaglutide and s.c. Cagrilintide on Glycemic Levels Measured by CGM

CHANTAL MATHIEU, SRIKANTH DEENADAYALAN, LARS ERICHSEN, JUAN P. FRIAS, FILIP K. KNOP, ILDIKO LINGVAY, EVA W. LEHMANN, SUE D. PEDERSEN, MELANIE J. DAVIES

Diabetes 2023;72(Supplement_1):54-OR

https://doi.org/10.2337/db23-54-OR

Published: 23 June 2023

View article titled, 54-OR: Effect of Coadministered s.c. Semaglutide and s.c. Cagrilintide on Glycemic Levels Measured by CGM

Meeting Abstracts

1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans

MAGNUS F.G. GRØNDAHL, CAROLINE T. JUEL, ASGER LUND, SOFIE HAEDERSDAL, MARIA M. ANDERSEN, JENS S. SVENNINGSEN, MATTHEW GILLUM, BOLETTE HARTMANN, JENS J. HOLST, TINA VILSBØLL, FILIP K. KNOP

Diabetes 2023;72(Supplement_1):1651-P

https://doi.org/10.2337/db23-1651-P

Published: 20 June 2023

View article titled, 1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans

Meeting Abstracts

285-LB: LEAP2 Reduces Preprandial and Postprandial Glucose Levels and Ad Libitum Food Intake in Obese Men

ANDERS ENGLUND, CHRISTOFFER A. HAGEMANN, LÆRKE S. GASBJERG, FILIP K. KNOP

Diabetes 2023;72(Supplement_1):285-LB

https://doi.org/10.2337/db23-285-LB

Published: 20 June 2023

View article titled, 285-LB: LEAP2 Reduces Preprandial and Postprandial Glucose Levels and Ad Libitum Food Intake in Obese Men

Meeting Abstracts

389-P: Glycemia and Cardiac Arrhythmias in People with Type 1 Diabetes

PER G. HAGELQVIST, ANDREAS ANDERSEN, KAISAR MAYTHAM, CHRISTINE R. ANDREASEN, SUSANNE ENGBERG, TOMMI B. LINDHARDT, JULIE FORMAN, ULRIK PEDERSEN-BJERGAARD, FILIP K. KNOP, TINA VILSBØLL

Diabetes 2023;72(Supplement_1):389-P

https://doi.org/10.2337/db23-389-P

Published: 20 June 2023

View article titled, 389-P: Glycemia and Cardiac Arrhythmias in People with Type 1 Diabetes

Meeting Abstracts

244-OR: Signs of Glucagon Resistance after a Two-Week Hypercaloric Diet Intervention

MALTE P. SUPPLI, JONATAN I. BAGGER, SR., JENS J. HOLST, FILIP K. KNOP

Diabetes 2023;72(Supplement_1):244-OR

https://doi.org/10.2337/db23-244-OR

Published: 20 June 2023

View article titled, 244-OR: Signs of Glucagon Resistance after a Two-Week Hypercaloric Diet Intervention

Meeting Abstracts

801-P: Short-Acting Exenatide Added Three Times Daily to Insulin Therapy Improves Fatty Liver Index in Type 1 Diabetes

NICKLAS JOHANSEN, THOMAS F. DEJGAARD, ASGER LUND, CASPER K. NIELSEN, TINA VILSBØLL, FILIP K. KNOP

Diabetes 2023;72(Supplement_1):801-P

https://doi.org/10.2337/db23-801-P

Published: 20 June 2023

View article titled, 801-P: Short-Acting Exenatide Added Three Times Daily to Insulin Therapy Improves Fatty Liver Index in Type 1 Diabetes

Meeting Abstracts

1658-P: Rectal Hyposensitivity, a Potential Marker of Enteric Autonomic Nerve Dysfunction, Is Significantly Associated with Gastrointestinally Mediated Glucose Disposal in Persons with Type 2 Diabetes

SONDRE MELING, ERLING TJORA, NIELS EJSKJAER, SIRI CARLSEN, FILIP K. KNOP, PÅL RASMUS NJØLSTAD, CHRISTINA BROCK, RASMUS B. NEDERGAARD, EIRIK SØFTELAND

Diabetes 2023;72(Supplement_1):1658-P

https://doi.org/10.2337/db23-1658-P

Published: 20 June 2023

View article titled, 1658-P: Rectal Hyposensitivity, a Potential Marker of Enteric Autonomic Nerve Dysfunction, Is Significantly Associated with Gastrointestinally Mediated Glucose Disposal in Persons with Type 2 Diabetes

Meeting Abstracts

143-OR: Prevailing Glucose Levels Alter Left Ventricular Contractions Pattern, Myocardial Performance, and Myocardial Energy Efficiency

CHRISTINE R. ANDREASEN, ANDREAS ANDERSEN, PER G. HAGELQVIST, KAISAR MAYTHAM, MORTEN SENGELØV, FILIP K. KNOP, FLEMMING J. OLSEN, TINA VILSBØLL

Diabetes 2023;72(Supplement_1):143-OR

https://doi.org/10.2337/db23-143-OR

Published: 20 June 2023

View article titled, 143-OR: Prevailing Glucose Levels Alter Left Ventricular Contractions Pattern, Myocardial Performance, and Myocardial Energy Efficiency

Meeting Abstracts

56-OR: A Long-Acting Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist Shows Weight Loss without Nausea or Vomiting

FILIP K. KNOP, SHWETA URVA, MALLIKARJUNA RETTIGANTI, CHARLES BENSON, WILLIAM ROELL, KIEREN J. MATHER, AXEL HAUPT, EDWARD J. PRATT

Diabetes 2023;72(Supplement_1):56-OR

https://doi.org/10.2337/db23-56-OR

Published: 20 June 2023

View article titled, 56-OR: A Long-Acting Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist Shows Weight Loss without Nausea or Vomiting

Journal Articles

Endogenous Glucose-Dependent Insulinotropic Polypeptide Contributes to Sitagliptin-Mediated Improvement in β-Cell Function in Patients With Type 2 Diabetes

Signe Stensen, Lærke S. Gasbjerg, Mette M. Rosenkilde, Tina Vilsbøll, Jens J. Holst, Bolette Hartmann, Mikkel B. Christensen, Filip K. Knop

Diabetes 2022;71(10):2209–2221

https://doi.org/10.2337/db22-0059

Published: 07 July 2022

View article titled, Endogenous Glucose-Dependent Insulinotropic Polypeptide Contributes to Sitagliptin-Mediated Improvement in β-Cell Function in Patients With Type 2 Diabetes

Journal Articles

The Liver–α-Cell Axis in Health and in Disease

Michael M. Richter, Katrine D. Galsgaard, Emilie Elmelund, Filip K. Knop, Malte P. Suppli, Jens J. Holst, Marie Winther-Sørensen, Sasha A.S. Kjeldsen, Nicolai J. Wewer Albrechtsen

Diabetes 2022;71(9):1852–1861

https://doi.org/10.2337/dbi22-0004

Published: 03 June 2022

View article titled, The Liver–α-Cell Axis in Health and in Disease

Meeting Abstracts

235-OR: Sustained QTc Prolongation during Recovery from Hypoglycemia in Patients with Type 1 Diabetes

CHRISTINE R. ANDREASEN, ANDREAS ANDERSEN, PER G. HAGELQVIST, JULIUS V. LAURITSEN, SUSANNE ENGBERG, JENS J. HOLST, ULRIK PEDERSEN-BJERGAARD, FILIP K. KNOP, TINA VILSBØLL

Diabetes 2022;71(Supplement_1):235-OR

https://doi.org/10.2337/db22-235-OR

Published: 01 June 2022

View article titled, 235-OR: Sustained QTc Prolongation during Recovery from Hypoglycemia in Patients with Type 1 Diabetes

Meeting Abstracts

182-OR: Clinical Effects of SGLT2 Inhibitors in HNF1A-Diabetes (MODY3) : A Case Series

HENRIK MAAGENSEN, SOFIE HAEDERSDAL, JESPER KROGH, TORBEN HANSEN, FILIP K. KNOP, TINA VILSBØLL

Diabetes 2022;71(Supplement_1):182-OR

https://doi.org/10.2337/db22-182-OR

Published: 01 June 2022

View article titled, 182-OR: Clinical Effects of SGLT2 Inhibitors in HNF1A-Diabetes (MODY3) : A Case Series

Meeting Abstracts

1362-P: Endogenous Glucose-Dependent Insulinotropic Polypeptide Facilitates Postprandial Intestinal Lipid Uptake in Healthy Men, but Not in Patients with Type 2 Diabetes

LÆRKE S. GASBJERG, MADS M. HELSTED, SIGNE STENSEN, LIVA S.L. KROGH, ALEXANDER H. SPARRE-ULRICH, BOLETTE HARTMANN, TINA VILSBØLL, MIKKEL B. CHRISTENSEN, JENS J. HOLST, CHRISTINA CHRISTOFFERSEN, FILIP K. KNOP, METTE M. ROSENKILDE

Diabetes 2022;71(Supplement_1):1362-P

https://doi.org/10.2337/db22-1362-P

Published: 01 June 2022

View article titled, 1362-P: Endogenous Glucose-Dependent Insulinotropic Polypeptide Facilitates Postprandial Intestinal Lipid Uptake in Healthy Men, but Not in Patients with Type 2 Diabetes

Meeting Abstracts

745-P: Short-Acting Exenatide Added Three Times Daily to Insulin Therapy Improves Insulin Sensitivity in Type 1 Diabetes

NICKLAS JOHANSEN, THOMAS F. DEJGAARD, ASGER LUND, TINA VILSBØLL, HENRIK U. ANDERSEN, FILIP K. KNOP

Diabetes 2022;71(Supplement_1):745-P

https://doi.org/10.2337/db22-745-P

Published: 01 June 2022

View article titled, 745-P: Short-Acting Exenatide Added Three Times Daily to Insulin Therapy Improves Insulin Sensitivity in Type 1 Diabetes

Meeting Abstracts

734-P: The Effect of Adjunctive Therapy with Liraglutide on Insulin Sensitivity in Overweight Persons with Type 1 Diabetes

THOMAS F. DEJGAARD, CHRISTIAN S. FRANDSEN, NICKLAS JOHANSEN, STEN MADSBAD, FILIP K. KNOP, HENRIK U. ANDERSEN

Diabetes 2022;71(Supplement_1):734-P

https://doi.org/10.2337/db22-734-P

Published: 01 June 2022

View article titled, 734-P: The Effect of Adjunctive Therapy with Liraglutide on Insulin Sensitivity in Overweight Persons with Type 1 Diabetes

NARROW

Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis

909-P: Impact of SGLT2 Inhibition on Glucosuria in HNF1A-MODY

1598-P: Transcriptional Profiling of the Intestinal Tract in Type 2 Diabetes—Unraveling Pathophysiological Pathways for Therapeutic Insights

53-OR: Efficacy and Safety of Coadministered s.c. Semaglutide and s.c. Cagrilintide in Type 2 Diabetes

54-OR: Effect of Coadministered s.c. Semaglutide and s.c. Cagrilintide on Glycemic Levels Measured by CGM

1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans

285-LB: LEAP2 Reduces Preprandial and Postprandial Glucose Levels and Ad Libitum Food Intake in Obese Men

389-P: Glycemia and Cardiac Arrhythmias in People with Type 1 Diabetes

244-OR: Signs of Glucagon Resistance after a Two-Week Hypercaloric Diet Intervention

801-P: Short-Acting Exenatide Added Three Times Daily to Insulin Therapy Improves Fatty Liver Index in Type 1 Diabetes

1658-P: Rectal Hyposensitivity, a Potential Marker of Enteric Autonomic Nerve Dysfunction, Is Significantly Associated with Gastrointestinally Mediated Glucose Disposal in Persons with Type 2 Diabetes

143-OR: Prevailing Glucose Levels Alter Left Ventricular Contractions Pattern, Myocardial Performance, and Myocardial Energy Efficiency

56-OR: A Long-Acting Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist Shows Weight Loss without Nausea or Vomiting

Endogenous Glucose-Dependent Insulinotropic Polypeptide Contributes to Sitagliptin-Mediated Improvement in β-Cell Function in Patients With Type 2 Diabetes

The Liver–α-Cell Axis in Health and in Disease

235-OR: Sustained QTc Prolongation during Recovery from Hypoglycemia in Patients with Type 1 Diabetes

182-OR: Clinical Effects of SGLT2 Inhibitors in HNF1A-Diabetes (MODY3) : A Case Series

1362-P: Endogenous Glucose-Dependent Insulinotropic Polypeptide Facilitates Postprandial Intestinal Lipid Uptake in Healthy Men, but Not in Patients with Type 2 Diabetes

745-P: Short-Acting Exenatide Added Three Times Daily to Insulin Therapy Improves Insulin Sensitivity in Type 1 Diabetes

734-P: The Effect of Adjunctive Therapy with Liraglutide on Insulin Sensitivity in Overweight Persons with Type 1 Diabetes

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only